Consolidation chemotherapy with capecitabine after neoadjuvant chemoradiotherapy in high-risk patients with locally advanced rectal cancer: Propensity score study

doi:10.4251/wjgo.v14.i9.1711

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3303)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

141

WORD

HTML

1477

Figures (1-3)

489

Tables (1-5)

182

Sum=2328

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

259

Download

716

Sum=975

Sep 15, 2022 (publication date) through Jan 2, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Oncol. Sep 15, 2022; 14(9): 1711-1726
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1711

Full Size Figure Download Figure

Figure 2 Forest plot of the subgroup analysis for complete response rate in the propensity score match cohort. Odds rate (OR) > 1 favors consolidation chemotherapy (CC) group, and OR < 1 favors non-CC group. CR: complete response; PSM: Propensity score match; CC: Consolidation chemotherapy; OR: Odds rate; CI: Confident interval; CEA: Carcinoma embryonic antigen; MRF: Mesorectal fascia; EMVI: Extralmural venous invasion.

Citation: Sheng XQ, Wang HZ, Li S, Zhang YZ, Geng JH, Zhu XG, Quan JZ, Li YH, Cai Y, Wang WH. Consolidation chemotherapy with capecitabine after neoadjuvant chemoradiotherapy in high-risk patients with locally advanced rectal cancer: Propensity score study. World J Gastrointest Oncol 2022; 14(9): 1711-1726
URL: https://www.wjgnet.com/1948-5204/full/v14/i9/1711.htm
DOI: https://dx.doi.org/10.4251/wjgo.v14.i9.1711